Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Disease area: Airway diseases

Abstract

Introduction: The prognostic value of mortality in the current systems of classification of chronic obstructive pulmonary disease (COPD) is a subject of controversy. The BODE index has proven to be a good tool to predict mortality in COPD.Objective: To evaluate the distribution of quartiles of the BODE index in each of the stages of COPD severity according to ALAT 2014 and GOLD 2013.Methods: Patients completed assessments to calculate the BODE index and history of exacerbations in the previous year. Patients were classified according to the proposals of gravity ALAT (mild, moderate, severe and very severe) and GOLD-2013 ABCD. Quartiles of the BODE index is analyzedResults: 100% of patients with mild COPD were classified in Q1 BODE, while 96.7% of patients were in GOLD A Q1. ALAT moderate stages were classified into Q1 (89.2%) and Q2 (10.8%), while B is classified in GOLD (Q1: 76.9% and Q2: 23.1%). Severe patients were divided into Q1: 37.5%; Q2: Q3 and 43.75%: 18.75%, while the seriously ill patients were distributed in the most advanced quartiles (Q2: 25%; Q3: 37.5%; Q4: 37.5%), C GOLD stages were distributed in Q1: 50%, Q2: 37.5% Q3 12.5% while the GOLD D were divided into 4 quartiles (Q1: 6.7%, Q2: 40%, Q3: 33.3% and Q4: 20 %)



Discussion: There is a good concordance for the distribution of quartiles of the BODE index in less severe stages of COPD, however, in severe stages greater heterogeneity in the distribution of BODE quartiles was found.


Rating:

Share or cite this content

Citations should be made in the following way:
Efrain José Sanchez Angarita (Caracas, Distrito Capital, Venezuela), Efrain Sanchez Angarita, Maria Eugenia Laucho-Contreras, Arteta Andres, Herrera Lesly, Palatz Rosana, Montes de Oca Maria. COPD staging systems and BODE index. Eur Respir J 2016; 48: Suppl. 60, 1023

Member's Comments

No comment yet.

Related content which might interest you: The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014 Is it possible to improve the prediction ability of the BODE index? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 i-BODE for evaluating the efficiency of pulmonary rehabilitation in patients with COPD Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013 COPD assessment for symptoms and functional condition in pulmonary rehabilitation Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Use of clinical characteristics to predict spirometric classification of obstructive lung disease Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014